Filter
327
Filtered Results: 327
Text search:
counterfeit
Featured
Recommendations
18
New Publications
98
Language
Document type
No document type
171
Studies & Reports
76
Guidelines
39
Manuals
15
Strategic & Response Plan
13
Fact sheets
6
Situation Updates
4
Training Material
3
Countries / Regions
Kenya
17
Global
11
Uganda
11
Ethiopia
11
Nigeria
10
Sierra Leone
8
Ghana
7
Liberia
7
Malawi
6
Tanzania
6
India
6
Rwanda
5
Zimbabwe
5
Cambodia
5
Western and Central Europe
5
Botswana
5
Myanmar / Burma
5
South–East Asia Region
4
Bangladesh
4
South Africa
4
Zambia
4
Ukraine
3
Syria
3
Senegal
3
Burkina Faso
3
Philippines
3
Africa
3
Haiti
3
Central African Republic
3
Mali
3
Eswatini/ Swaziland
3
Nepal
2
China
2
Cameroon
2
Congo, Democratic Republic of
2
Namibia
2
Indonesia
2
Tajikistan
1
Thailand
1
Lesotho
1
Benin
1
Laos
1
Guinea
1
Mozambique
1
Asia
1
Latin America and the Carribbean
1
West and Central Africa
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Turkmenistan
1
East and Southern Africa
1
Vietnam
1
Moldova
1
Sri Lanka
1
Yemen
1
Somalia
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
138
Public Health
16
Key Resources
15
Clinical Guidelines
12
Pharmacy & Technologies
8
Women & Child Health
4
Capacity Building
2
Toolboxes
AMR
44
Pharmacy
39
Mental Health
14
COVID-19
14
Planetary Health
12
TB
9
HIV
8
Health Financing Toolbox
8
Global Health Education
7
Conflict
6
Disability
5
Rapid Response
4
Refugee
3
Ebola
3
Natural Hazards
2
Caregiver
2
NCDs
2
Specific Hazards
1
Social Ethics
1
Polio
1
The main objectives of these guidelines are to:
1. contribute to the quality assurance of medicinal plant materials used as the source for herbal medicines to improve the quality, safety and efficacy of finished herbal products; 2. guide the formulation of national and/or regional GACP guideli...
1. contribute to the quality assurance of medicinal plant materials used as the source for herbal medicines to improve the quality, safety and efficacy of finished herbal products; 2. guide the formulation of national and/or regional GACP guideli...
The WHO Framework Convention on Tobacco Control (WHO FCTC) is an evidence-based treaty that reaffirms the right of all people to the highest standard of health and was developed in response to the globalization of the tobacco epidemic. Member States of the WHO South-East Asia Region have made...
The emergence of multifrug-resistant malaria in the Greater Mekong Subregion (GMS) has been identified as an emergency issue that may have catastrophic consequences on the future of malaria elimination in the GMS as well as globally. In recognition of the need for a cohesive regional response,...
Conducted November 2011 to February 2012: Summary Report
This summary report has five sections. Following the introduction (Section 1), Section 2 sets out summary findings and recommendations of the assessment team. Section 3 describes the context in which artemisinin resistance is being tackle...
This summary report has five sections. Following the introduction (Section 1), Section 2 sets out summary findings and recommendations of the assessment team. Section 3 describes the context in which artemisinin resistance is being tackle...
Recent efforts to fight malaria in the Greater Mekong Subregion (GMS) have yielded impressive results. According to the latest WHO estimates, the six GMS countries cut their malaria case incidence by an estimated 54% between 2012 and 2015. Malaria death rates fell by 84% over the same period.
I...
I...
A guidance document in simple language for health personnel, setting out their rights and responsibilities in conflict and other situations of violence. It explains how responsibilities and rights for health personnel can be derived from international humanitarian law, human rights law and medical e...
The report explores strategies for sustaining the country’s responses to the three diseases and eventually transitioning away from external funding and programmatic support. It takes stock of Kenya’s health financing landscape and identifies opportunities and challenges for sustaining effective ...
Poor quality health services are holding back progress on improving health in countries at all income levels.
Today, inaccurate diagnosis, medication errors, inappropriate or unnecessary treatment, inadequate or unsafe clinical facilities or practices, or providers who lack adequate training an...
Today, inaccurate diagnosis, medication errors, inappropriate or unnecessary treatment, inadequate or unsafe clinical facilities or practices, or providers who lack adequate training an...
Background Paper prepared for the 2015 Global Assessment Report on Disaster Risk Reduction
The aim of this paper is to help bring voluntary standards into the toolbox of disaster risk reduction, including both by encouraging their use by business and by enhancing their role in legislation and ...
The aim of this paper is to help bring voluntary standards into the toolbox of disaster risk reduction, including both by encouraging their use by business and by enhancing their role in legislation and ...
The National Health Plan (NHP) aims to strengthen the country’s health system and pave the way towards Universal Health Coverage (UHC),choosing a path that is explicitly pro-poor. The main goal of NHP 2017-2021 is to extend access to a Basic Essential Package of Health Services (EPHS) to the entir...
The main objective of the malaria prevention and control programme in Somalia is to prevent mortality and reduce morbidity due to malaria. The groups most vulnerable to the disease, children aged under 5 years and pregnant women, are especially targeted. Effective case management - early diagnosis a...
Situational Analysis: 13-23 October 2014
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
An update from the EU Early Warning System
World Drug Report 2017
-5-
Accessed: 14.03.2019
Amphetamine-type stimulants, new psychoactive substances
-4-
World Drug Report 2017
Accessed: 14.03.2019
World Drug Report 2017
-1-
Accessed: 14.03.2019
World Drug Report 2018
-3-
Attention-Deficit/Hyperactivity Disorder
